BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23350650)

  • 1. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.
    Shan Y; Schoenfeld RA; Hayashi G; Napoli E; Akiyama T; Iodi Carstens M; Carstens EE; Pook MA; Cortopassi GA
    Antioxid Redox Signal; 2013 Nov; 19(13):1481-93. PubMed ID: 23350650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frataxin deficiency leads to reduced expression and impaired translocation of NF-E2-related factor (Nrf2) in cultured motor neurons.
    D'Oria V; Petrini S; Travaglini L; Priori C; Piermarini E; Petrillo S; Carletti B; Bertini E; Piemonte F
    Int J Mol Sci; 2013 Apr; 14(4):7853-65. PubMed ID: 23574943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
    Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
    Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model.
    Tomassini B; Arcuri G; Fortuni S; Sandi C; Ezzatizadeh V; Casali C; Condò I; Malisan F; Al-Mahdawi S; Pook M; Testi R
    Hum Mol Genet; 2012 Jul; 21(13):2855-61. PubMed ID: 22447512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cofilin dysregulation alters actin turnover in frataxin-deficient neurons.
    Muñoz-Lasso DC; Mollá B; Calap-Quintana P; García-Giménez JL; Pallardo FV; Palau F; Gonzalez-Cabo P
    Sci Rep; 2020 Mar; 10(1):5207. PubMed ID: 32251310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
    Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.
    Mollá B; Muñoz-Lasso DC; Calap P; Fernandez-Vilata A; de la Iglesia-Vaya M; Pallardó FV; Moltó MD; Palau F; Gonzalez-Cabo P
    Neurotherapeutics; 2019 Apr; 16(2):432-449. PubMed ID: 30761510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich's ataxia.
    Mollá B; Riveiro F; Bolinches-Amorós A; Muñoz-Lasso DC; Palau F; González-Cabo P
    Dis Model Mech; 2016 Jun; 9(6):647-57. PubMed ID: 27079523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells from wildtype and Friedreich's ataxia mice present similar neuroprotective properties in dorsal root ganglia cells.
    Jones J; Estirado A; Redondo C; Martinez S
    PLoS One; 2013; 8(5):e62807. PubMed ID: 23671637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia Models.
    Abeti R; Baccaro A; Esteras N; Giunti P
    Front Cell Neurosci; 2018; 12():188. PubMed ID: 30065630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia.
    Hayashi G; Shen Y; Pedersen TL; Newman JW; Pook M; Cortopassi G
    Hum Mol Genet; 2014 Dec; 23(25):6838-47. PubMed ID: 25104852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia: An Impaired Nrf2 Response Mediated via Upregulation of Keap1 and Activation of the Gsk3β Axis.
    Anzovino A; Chiang S; Brown BE; Hawkins CL; Richardson DR; Huang ML
    Am J Pathol; 2017 Dec; 187(12):2858-2875. PubMed ID: 28935570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia.
    Nabhan JF; Wood KM; Rao VP; Morin J; Bhamidipaty S; LaBranche TP; Gooch RL; Bozal F; Bulawa CE; Guild BC
    Sci Rep; 2016 Feb; 6():20019. PubMed ID: 26883577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
    Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
    Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential biomarker identification for Friedreich's ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion.
    McMackin MZ; Durbin-Johnson B; Napierala M; Napierala JS; Ruiz L; Napoli E; Perlman S; Giulivi C; Cortopassi GA
    PLoS One; 2019; 14(10):e0223209. PubMed ID: 31665133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dilated cardiomyopathy in a mouse model of Friedreich's ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis.
    Chiang S; Huang MLH; Richardson DR
    Pharmacol Res; 2020 Sep; 159():104994. PubMed ID: 32534099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
    Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
    Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.